Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative)

Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative) is listed in the pharmaceutical impurity collection under CAS 79560-19-3. Its represented structure has formula C16H12Cl2O and a calculated molecular weight of 291.18 g/mol.

2D chemical structure

O C l C l

Chemical identity

Catalog name
Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative)
Common name
Sertraline Hydrochloride Imp. F (EP) as Racemate
Chemical name
4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative)
CAS
79560-19-3
SMILES
O=C1CCC(c2ccc(Cl)c(Cl)c2)c2ccccc21
InChI
InChI=1S/C16H12Cl2O/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11H,6,8H2
InChIKey
JGMBHJNMQVKDMW-UHFFFAOYSA-N
Associated API
Sertraline Hydrochloride

Record ID: Aedb679cf50d8

Computed properties

C16H12Cl2O Molecular formula
291.177 g/molMolecular weight
290.0265 DaMonoisotopic exact mass
17.07 ŲTopological polar surface area
5.1018 Calculated LogP (Wildman–Crippen)
78.3115 cm³/molMolar refractivity (Wildman–Crippen)
1 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 1 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 1 2 3 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H O 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight291.17741.47
Calculated LogP (Wildman–Crippen)5.101890.38
Topological polar surface area17.074.96
Hydrogen-bond acceptors14.43
Hydrogen-bond donors011.28
Rotatable bonds (strict)112.12

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC16H12Cl2Odimensionless
Molecular weight291.177g/mol
Monoisotopic exact mass290.0265Da
Topological polar surface area17.07Ų
Calculated LogP (Wildman–Crippen)5.1018dimensionless
Molar refractivity (Wildman–Crippen)78.3115cm³/mol
Hydrogen-bond acceptors1count
Hydrogen-bond donors0count
Rotatable bonds (strict)1count
Heavy atoms19count
Heteroatoms3count
Rings3count
Aromatic rings2count
Aliphatic rings1count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles1count
Fraction of sp³ carbon atoms0.1875fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters1count
Unspecified atom stereocenters1count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area121.7105Ų
Valence electrons96count
Radical electrons0count
Bertz complexity648.9472index
Balaban J2.0909index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative)

Qualification and safety assessment of Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative)

Explore toxicological qualification of Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative) and ICH M7 mutagenic impurity assessment of Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative) for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative) and acceptable intake and limit justification for Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative). The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Sertraline Hydrochloride Imp. F (EP) as Racemate: 4-(3,4-Dichlorophenyl)- 3,4-dihydronaphthalen-1(2H)-one (Sertraline Tetralone Derivative)

Explore Altox services and software through the Altox Pharma-Hub.